Natixis Corcept Therapeutics Inc Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $185,721 - $227,199	-9,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $156,054 - $253,890	9,300 New	9,300 $243,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $179,052 - $235,254	-11,354 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $139,654 - $219,132	11,354	11,354 $219,000

339

86.5M

1.27M

454K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.